Surgery Partners
SGRY
82 hedge funds and large institutions have $711M invested in Surgery Partners in 2018 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 23 increasing their positions, 33 reducing their positions, and 15 closing their positions.
1,875% more call options, than puts
Call options by funds: $316K | Put options by funds: $16K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 15
1% less funds holding
Funds holding: 83 → 82 (-1)
1.23% less ownership
Funds ownership: 98.75% → 97.52% (-1.2%)
14% less capital invested
Capital invested by funds: $823M → $711M (-$113M)
30% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 33
Top Buyers
Top Sellers
| 1 |
Goldman Sachs
New York
|
-$7.87M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$6.71M |
| 3 |
JP Morgan Chase
New York
|
-$5.22M |
| 4 |
Norges Bank
Oslo,
Norway
|
-$4.98M |
| 5 |
TCM
TimesSquare Capital Management
New York
|
-$4.87M |
SGRY Hedge Fund Activity: Q2 2018 in Review
82 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Surgery Partners (SGRY) for Q2 2018, worth a combined $711M — down 14% from $823M a quarter earlier.
Fund positioning in SGRY was balanced in Q2 2018: 15 funds opened new positions, 15 closed out, 23 added to existing stakes and 33 trimmed.
The largest buyer was Redmile Group, opening a new position worth an estimated $10.4M. The largest seller was Goldman Sachs, exiting entirely with an estimated $7.87M sold.
- 82 institutional investors held Surgery Partners (SGRY) as of Q2 2018, down from 83 in Q1 2018.
- Funds reported $711M of Surgery Partners stock for Q2 2018, down 14% quarter-over-quarter.
- 15 funds opened new Surgery Partners positions in Q2 2018 and 15 closed out, a net change of 0 holders.
- The largest Surgery Partners buyer in Q2 2018 was Redmile Group, an estimated $10.4M added.
- The largest Surgery Partners seller in Q2 2018 was Goldman Sachs, an estimated $7.87M sold.
Based on aggregated 13F filings for Q2 2018.